Suivre
Timothée Bruel
Timothée Bruel
Adresse e-mail validée de pasteur.fr
Titre
Citée par
Citée par
Année
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ...
Nature 596 (7871), 276-280, 2021
21372021
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ...
Nature 602 (7898), 671-675, 2022
13182022
IgA dominates the early neutralizing antibody response to SARS-CoV-2
D Sterlin, A Mathian, M Miyara, A Mohr, F Anna, L Claër, P Quentric, ...
Science translational medicine 13 (577), eabd2223, 2021
9492021
Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies
D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ...
Nature medicine 27 (5), 917-924, 2021
7202021
Syncytia formation by SARS‐CoV‐2‐infected cells
J Buchrieser, J Dufloo, M Hubert, B Monel, D Planas, MM Rajah, ...
The EMBO journal 39 (23), e106267, 2020
3912020
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ...
Science translational medicine 12 (559), eabc3103, 2020
333*2020
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
B Descours, G Petitjean, JL López-Zaragoza, T Bruel, R Raffel, C Psomas, ...
Nature 543 (7646), 564-567, 2017
2882017
Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies
T Bruel, J Hadjadj, P Maes, D Planas, A Seve, I Staropoli, ...
Nature medicine 28 (6), 1297-1302, 2022
2512022
IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread
AA Compton, T Bruel, F Porrot, A Mallet, M Sachse, M Euvrard, C Liang, ...
Cell host & microbe 16 (6), 736-747, 2014
2322014
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
T Bruel, F Guivel-Benhassine, S Amraoui, M Malbec, L Richard, K Bourdic, ...
Nature communications 7 (1), 10844, 2016
229*2016
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
F Gallais, P Gantner, T Bruel, A Velay, D Planas, MJ Wendling, S Bayer, ...
EBioMedicine 71, 2021
220*2021
Cluster of COVID-19 in northern France: a retrospective closed cohort study
A Fontanet, L Tondeur, Y Madec, R Grant, C Besombes, N Jolly, ...
MedRxiv, 2020.04. 18.20071134, 2020
2022020
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
S Marot, I Malet, V Leducq, K Zafilaza, D Sterlin, D Planas, A Gothland, ...
Nature communications 12 (1), 844, 2021
1812021
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
R Robinot, M Hubert, GD de Melo, F Lazarini, T Bruel, N Smith, ...
Nature communications 12 (1), 1-16, 2021
179*2021
Zika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells
B Monel, AA Compton, T Bruel, S Amraoui, J Burlaud‐Gaillard, N Roy, ...
The EMBO journal 36 (12), 1653-1668, 2017
1402017
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
S Fafi-Kremer, T Bruel, Y Madec, R Grant, L Tondeur, L Grzelak, ...
EBioMedicine 59, 2020
1252020
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
N Smith, P Goncalves, B Charbit, L Grzelak, M Beretta, C Planchais, ...
Nature immunology 22 (11), 1428-1439, 2021
1242021
Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies
D Planas, T Bruel, I Staropoli, F Guivel-Benhassine, F Porrot, P Maes, ...
Nature communications 14 (1), 824, 2023
1202023
SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission
A Fontanet, R Grant, L Tondeur, Y Madec, L Grzelak, I Cailleau, ...
MedRxiv, 2020
99*2020
Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2
L Grzelak, A Velay, Y Madec, F Gallais, I Staropoli, C Schmidt-Mutter, ...
The Journal of infectious diseases 224 (6), 983-988, 2021
922021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20